Volume: 28 Issue: 7

1. Clinical significance of serum testosterone levels in young and middle-aged men with type 2 diabetes mellitus accompanied by erectile dysfunction Page:570—571
2. The single nucleotide polymorphisms in the intron 1 of TSHR gene were associated with Graves' disease Page:565—569
3. Association between mitochondrial uncoupling protein 2 gene promoter -866G>A polymorphism and ischemic stroke in diabetic patients Page:561—564
4. Final height outcome of boys with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogue Page:551—556
5. The advances of research on adrenal diseases from 2010 to 2012 Page:526—532
6. Adiponectin activates AMP-activated protein kinase via LKB1 pathway Page:578—583
7. Outcome of postoperative hypopituitarism and hormone replacement situation in 215 patients with pituitary adenoma Page:546—550
8. The value of bilateral inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome Page:537—541
9. Liraglutide improves the rate of achieving composite outcome in patients with type 2 diabetes Page:609—612
10. Approach to the patient with pituitary carcinoma Page:593—596
11. Role of oxLDL/LOX-1 system and NF-κB pathway in early diabetic vascular endothelial dysfunction Page:589—592
12. A survey on the iodine nutrition status and thyroid function in rural population of Jilin province Page:575—577
13. Association of single nucleotide polymorphism of interleukin 6 receptor gene and metabolic syndrome Page:572—574
14. Clinical characteristics of 54 cases with Sheehan's syndrome Page:557—560
15. Investigation on evaluation of pituitary function after transsphenoidal ectomy of hypophysoma Page:542—545
16. Update on nonalcoholic fatty liver disease Page:533—536
17. Progress of genetic studies on serum TSH levels Page:602—606
18. Progress in the study of thyroid hormone analogues Page:599—601
19. Effect of levothyroxine and vitamin E treatment on oxidative stress and myocardial apoptosis in rats with hypothyroidism Page:584—588
20. Reducing the imperfection of pituitary adenoma treatment Page:525—